Insulin: Difference between revisions
No edit summary |
No edit summary |
||
(7 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
==Types== | ==Types== | ||
{| | {| class="wikitable" | ||
|- | |- | ||
| <u>'''Type'''</u> | | <u>'''Type'''</u> | ||
Line 48: | Line 48: | ||
| 6-8 | | 6-8 | ||
|- | |- | ||
| colspan="5" | INTERMEDIATE ACTING | | colspan="5" | '''INTERMEDIATE ACTING''' | ||
|- | |- | ||
| NPH | | NPH | ||
Line 79: | Line 79: | ||
|} | |} | ||
[[File:Insulin.jpg|thumbnail]] | |||
{{Common Anti-hyperglycemic Drugs and Pharmacology}} | |||
==Insulin Sliding Scale== | ==Insulin Sliding Scale== | ||
*Dosing depends on the patient's level of insulin resistance | *Dosing depends on the patient's level of insulin resistance. | ||
*The example sliding scales are for regular insulin with blood glucose (BG) measured in mg/dL | *The example sliding scales are for regular insulin with blood glucose (BG) measured in mg/dL | ||
===Low Dose === | ===Low Dose (Renal Insufficiency)=== | ||
*BG 150-199: 1 unit bolus Insulin | *BG 150-199: 1 unit bolus Insulin | ||
*BG 200-249: 2 units bolus Insulin | *BG 200-249: 2 units bolus Insulin | ||
Line 92: | Line 94: | ||
*BG Over 350: 5 units bolus Insulin | *BG Over 350: 5 units bolus Insulin | ||
===Medium Dose=== | ===Medium Dose (Standard)=== | ||
*BG 150-199: 1 unit bolus Insulin | *BG 150-199: 1 unit bolus Insulin | ||
*BG 200-249: 3 units bolus Insulin | *BG 200-249: 3 units bolus Insulin | ||
Line 99: | Line 101: | ||
*BG Over 350: 8 units bolus Insulin | *BG Over 350: 8 units bolus Insulin | ||
===High Dose=== | ===High Dose (Severely Insulin Resistant)=== | ||
*BG 150-199: 2 unit bolus Insulin | *BG 150-199: 2 unit bolus Insulin | ||
*BG 200-249: 4 units bolus Insulin | *BG 200-249: 4 units bolus Insulin | ||
Line 109: | Line 111: | ||
*[[Diabetes (Main)]] | *[[Diabetes (Main)]] | ||
[[Category: | [[Category:Pharmacology]] | ||
[[Category: | [[Category:Endocrinology]] |
Latest revision as of 07:47, 9 June 2016
Types
Type | Onset of action (h) | Peak action | Effective duration | Max duration |
RAPID ACTING | ||||
Lispro (humalog) |
0.25-0.5 |
0.5-1.25 | 3-4 | 4-6 |
Aspart (novolog) |
0.25-0.5 |
0.5-1.25 | 3-4 | 4-6 |
Glulisine (apidra) |
0.25-0.5 | 0.25-1.25 |
3-4 | 4-6 |
SHORT ACTING | ||||
Regular | 0.5-1 | 2-3 | 3-6 | 6-8 |
INTERMEDIATE ACTING | ||||
NPH | 2-4 | 6-10 | 10-16 | 14-18 |
LONG ACTING | ||||
glargine (Lantus) |
3-4 | 8-16 | 18-20 | 20-24 |
detemir (Levemir) |
3-4 | 6-8 | 14 | ~20 |
Common Anti-hyperglycemic Drugs and Pharmacology
Drug | Pharmacology | ||
---|---|---|---|
Onset | Peak | Duration | |
Rapid-acting insulin
|
15-30min | 1-2h | 3-5h |
Short-acting insulin
|
30-60min | 2-4h | 6-10h |
Intermediate-acting insulin
|
1-3h | 4-12h | 18-24h |
Long-acting insulin
|
2-4h | None | 24h |
Sulfonylurea
|
– | 2-6h | 12-24h |
See also GLP-1 agonists
Insulin Sliding Scale
- Dosing depends on the patient's level of insulin resistance.
- The example sliding scales are for regular insulin with blood glucose (BG) measured in mg/dL
Low Dose (Renal Insufficiency)
- BG 150-199: 1 unit bolus Insulin
- BG 200-249: 2 units bolus Insulin
- BG 250-299: 3 units bolus Insulin
- BG 300-349: 4 units bolus Insulin
- BG Over 350: 5 units bolus Insulin
Medium Dose (Standard)
- BG 150-199: 1 unit bolus Insulin
- BG 200-249: 3 units bolus Insulin
- BG 250-299: 5 units bolus Insulin
- BG 300-349: 7 units bolus Insulin
- BG Over 350: 8 units bolus Insulin
High Dose (Severely Insulin Resistant)
- BG 150-199: 2 unit bolus Insulin
- BG 200-249: 4 units bolus Insulin
- BG 250-299: 7 units bolus Insulin
- BG 300-349: 10 units bolus Insulin
- BG Over 350: 12 units bolus Insulin